Oct 29, 2025 4:05pm EDT OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
Oct 29, 2025 8:00am EDT OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Oct 28, 2025 8:00am EDT OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
Sep 15, 2025 8:30am EDT Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Jul 31, 2025 4:05pm EDT OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results
Jul 08, 2025 8:00am EDT OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress
Jun 25, 2025 11:00am EDT OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium
Jun 25, 2025 8:00am EDT OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting